BERKSHIRE HATHAWAY INC (BRK-B) vs PFIZER INC(PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | BRK-B | PFE |
|---|---|---|
| Sector | Financials | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $371.44B | $62.58B |
| Revenue growth (YoY) | ▲ 0.0% | ▼ 1.6% |
| Net income | $67.26B | $7.81B |
| Gross margin | — | — |
| Diluted EPS | — | $1.36 |
| Insider net (6 mo) | −787.6K sh · 4 sells · 2 buys | +130.5K sh · 2 sells · 3 buys |
| Institutional owners | 50 | 44 |
| Institutional value held | $215.24B | $61.93B |
| Next earnings (est.) | Around Nov 2, 2026 | Nov 3, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About BERKSHIRE HATHAWAY INC (BRK-B)
Berkshire Hathaway Inc., a Delaware-domiciled holding company headquartered in Omaha, Nebraska, operates a diverse portfolio of businesses managed under a highly decentralized structure, with its Chief Executive Officer responsible for major capital allocation
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across b
Source: SEC EDGAR.